Z
Zoufang Huang
Researcher at Southern Medical University
Publications - 16
Citations - 70
Zoufang Huang is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 28 citations.
Papers
More filters
Journal ArticleDOI
Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
Yiming Tian,Zoufang Huang,Zhixiang Wang,Changxin Yin,Lanlan Zhou,Lingxiu Zhang,Kaikai Huang,Hongsheng Zhou,Xuejie Jiang,Jinming Li,Libin Liao,Mo Yang,Fanyi Meng +12 more
TL;DR: Ang2 and FIS1 seem related to decreased CR rate of AML patients, and PDCD7 is associated with shorter OS and RFS in CN-AML, which may indicate a more aggressive form and poor prognosis ofAML.
Journal ArticleDOI
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang,Vivek P. Chavda,Lalitkumar K. Vora,Normi D. Gajjar,Vasso Apostolopoulos,Nirav Shah,Zhe-Sheng Chen +6 more
TL;DR: The development process, synthesis, mechanism of viral eradication, and preclinical and clinical development of 2-DG and its derivatives as molecularly targeted therapeutics for COVID-19 treatment are described.
Journal ArticleDOI
The Potential Role of Exosomes in the Treatment of Brain Tumors, Recent Updates and Advances
TL;DR: This research suggested that exosomes of nanoscale sizes might be a useful tool for crossing the blood-brain barrier and delivering effective content in brain tumor therapy protocols.
Journal ArticleDOI
CAR T-Cell therapy for the management of mantle cell lymphoma
TL;DR: In this paper , a brief synopsis of the development of CAR T-cell therapy for MCL is presented, and the FDA has approved brexucabtagene autoleucel (Tecartus, KTE-X19) to be used in patients with MCL who have not responded to previous treatments or have relapsed.
Journal ArticleDOI
CAR T cells: engineered immune cells to treat brain cancers and beyond
Zoufang Huang,Saikat Dewanjee,Pratik Chakraborty,Niraj K. Jha,Abhijit Dey,Moumita Gangopadhyay,Xuanhe Chen,Jian Wang,Saurabh Kumar Jha +8 more
TL;DR: In this paper , a thorough analysis of CAR T cells' promise in treating brain cancer, including design and delivery considerations, current strides in clinical and preclinical research, issues encountered, and potential solutions are presented.